Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 12Thoracic 2Sarcoma 1Plasma cell 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 35Ovarian Neoplasms 31Endometrial Neoplasms 13Uterine Cervical Dysplasia 10Papillomavirus Infections 9Breast Neoplasms 9Uterine Neoplasms 7Ovarian Cysts 6Lung Neoplasms 6Stomach Neoplasms 4Neoplasms 4Esophageal Neoplasms 4Carcinoma, Ovarian Epithelial 4Polycystic Ovary Syndrome 3Ovarian Hyperstimulation Syndrome 3Liver Neoplasms 3Leiomyoma 3Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Vomiting 2Uterine Diseases 2Urinary Bladder Neoplasms 2Tobacco Use Disorder 2Squamous Intraepithelial Lesions 2Small Cell Lung Carcinoma 2Recurrence 2Peritoneal Neoplasms 2Pancreatic Neoplasms 2

Interventions

Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Venous Thromboembolism × Gynecologic × Clear all
NCT04352439 2022-09-26

Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

Duke University

Phase 4 Completed
19 enrolled 10 charts
Classical hematologyGynecologic

Ovarian Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡